Wolff Wiese Magana’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58K Hold
85
﹤0.01% 707
2026
Q1
$2.25K Hold
85
﹤0.01% 761
2025
Q4
$2.46K Hold
85
﹤0.01% 718
2025
Q3
$2.36K Hold
85
﹤0.01% 728
2025
Q2
$2.07K Hold
85
﹤0.01% 721
2025
Q1
$1.76K Hold
85
﹤0.01% 746
2024
Q4
$2K Hold
85
﹤0.01% 705
2024
Q3
$2.18K Hold
85
﹤0.01% 727
2024
Q2
$2K Hold
85
﹤0.01% 547
2024
Q1
$2.44K Hold
85
﹤0.01% 485
2023
Q4
$2.79K Hold
85
﹤0.01% 443
2023
Q3
$2.37K Hold
85
﹤0.01% 529
2023
Q2
$2.9K Sell
85
-267
-76% -$8.39K ﹤0.01% 511
2023
Q1
$10.6K Hold
352
0.01% 340
2022
Q4
$9.94K Hold
352
0.01% 329
2022
Q3
$12K Hold
352
0.01% 472
2022
Q2
$11K Sell
352
-279
-44% -$9.76K 0.01% 515
2022
Q1
$29K Buy
631
+432
+217% +$20.6K 0.02% 349
2021
Q4
$12K Buy
199
+89
+81% +$6.15K 0.01% 509
2021
Q3
$8K Hold
110
0.01% 547
2021
Q2
$10K Hold
110
0.01% 503
2021
Q1
$10K Hold
110
0.01% 472
2020
Q4
$10K Buy
+110
New +$8.76K 0.01% 445

Other funds holding ARKG

Wolff Wiese Magana's ARKG Position: Q2 2026 in Review

Wolff Wiese Magana held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 85 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Wolff Wiese Magana first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $29K in Q1 2022. 71 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Wolff Wiese Magana held 85 shares of ARK Genomic Revolution ETF worth $3.58K as of Q2 2026.
  • Wolff Wiese Magana left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #707 holding.
  • Wolff Wiese Magana first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's ARK Genomic Revolution ETF position peaked at $29K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.